Prostate Cancer Study of Patient Experiences
Launched by ANKARA UNIVERSITY · Jul 24, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study, called PROSPEX, is designed to learn more about the everyday experiences of men living with prostate cancer. It aims to understand the challenges they face, including how the disease affects their mental health, social life, and practical needs like getting medical care. By gathering information directly from patients through an online survey, the study hopes to find ways to improve support and care for people with prostate cancer in the future.
Men of any age who have been diagnosed with prostate cancer—whether it's in an early stage, more advanced, or has come back—may be able to take part. To join, participants need to be able to understand the study, agree to take part, and complete the survey online using a computer, tablet, or smartphone. This study does not involve any treatment or medical procedures; it’s about sharing personal experiences to help improve care for others. Currently, the study is not yet recruiting participants.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Adults (aged 18 years or older). Diagnosed with prostate cancer at any stage (localized, locally advanced, metastatic, or recurrent).
- • Able to understand and provide informed consent for participation. Willing and able to complete the online survey in the available languages. Access to the internet and a device to complete the survey.
- Exclusion Criteria:
- • Individuals who have not been diagnosed with prostate cancer. Individuals under 18 years of age. Inability to provide informed consent. Inability to complete the survey due to cognitive, language, or technical barriers.
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Yüksel Ürün
Study Director
Ankara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported